Search filters

List of works by Jean-Baptiste Bachet

A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial

scientific article

Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti-EGFR antibodies in colorectal cancer.

scientific article published in September 2010

Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuva

scientific article published on 20 August 2012

Analysis of Base-Position Error Rate of Next-Generation Sequencing to Detect Tumor Mutations in Circulating DNA.

scientific article published on 13 September 2016

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

scientific article

Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma

scientific article published on October 2015

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

scientific article published on 28 September 2009

CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.

scientific article

Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness

scientific article published on 04 October 2016

Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer.

scientific article published on 8 April 2008

Cetuximab efficacy in patients treated routinely in university hospitals

scientific article published in November 2007

Chemotherapy as initial treatment of locally advanced unresectable pancreatic cancer: a valid option?

scientific article published on 01 February 2007

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

scientific article published on 14 May 2013

Colorectal cancer: what progress can we anticipate in the next few years?

scientific article published on 01 October 2010

Colorectal neuroendocrine carcinomas and adenocarcinomas share oncogenic pathways. A clinico-pathologic study of 12 cases.

scientific article

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): a retrospective review of 114 patients from the French sarcoma group (FSG).

scientific article published on 28 May 2014

Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

scientific article published on 29 February 2012

Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.

scientific article published on 6 November 2014

Current standards and new innovative approaches for treatment of pancreatic cancer.

scientific article published on 3 February 2016

Cutaneous adverse reactions of EGFR (epidermal growth factor receptor)-inhibitors: therapeutic algorithm of the French PROCUR group

scientific article published in May 2013

DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer.

scientific article published on 18 October 2016

Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.

scientific article published on 3 May 2013

Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors.

scientific article published on 29 October 2010

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

scientific article published on 26 April 2017

Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.

scientific article published on 30 October 2012

Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective study.

scientific article

FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohort.

scientific article

Feasibility of Immunohistochemistry on Endoscopic Ultrasound Fine-Needle Aspiration Samples for Evaluating Predictive Biomarkers in Pancreatic Cancer Management

scientific article published on 01 October 2016

Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review ⬇️

scientific article published on March 16, 2012

From Chemotherapy to Targeted Therapy in Adjuvant Treatment for Stage III Colon Cancer ⬇️

scientific article published on August 1, 2011

GIST with homozygous KIT exon 11 mutations

scientific article published on 01 May 2008

Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples

scientific article

Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

scientific article

High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.

scientific article

Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.

scientific article

Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies

scientific article published on 22 December 2014

Irinotecan as palliative chemotherapy for metastatic colorectal cancer: evolving tactics following initial treatment.

scientific article published on 17 February 2009

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

scientific article

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

scientific article

Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma

scientific article published on 13 June 2012

Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor

scientific article published on 13 November 2012

Long-term portosystemic shunt patency as a determinant of outcome in Budd–Chiari syndrome

Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution

scientific article published on April 2016

Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.

scientific article published on 27 April 2012

Molecular changes in pancreatic cancer: implications for molecular targeting therapy.

scientific article published on June 2012

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial

scientific article

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort

scientific article

New challenges in perioperative management of pancreatic cancer

scientific article

New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel.

scientific article published on August 2011

Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma.

scientific article

PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker.

scientific article published on 27 June 2017

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer

scientific article published on 24 January 2016

Pancreatic adenocarcinoma: ESMO–ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up ⬇️

scientific article published on October 1, 2012

Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study.

scientific article published on 05 October 2012

Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study.

scientific article published on 9 August 2016

Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker

scientific article

Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in KRAS, and BRAF(V600E) in Patients with Lymph Node-Positive Colon Cancer

scientific article

Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort

scientific article published on 24 January 2015

Rectal cancer and adjuvant chemotherapy: which conclusions?

scientific article published in January 2010

Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases

scientific article published on 16 April 2013

S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.

scientific article published on 28 May 2013

Salvage colectomy for endoscopically removed malignant colon polyps: is it possible to determine the optimal number of lymph nodes that need to be harvested?

scientific article published on 01 January 2012

Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: feasibility and potential benefits in a retrospective series of 117 patients

scientific article published on 15 September 2009

Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues.

scientific article published on 5 June 2015

Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma

scientific article published on 31 December 2014

Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physicians.

scientific article published on 3 January 2012

Treatment of pancreatic cancer: what can we really predict today?

scientific article published on 17 February 2011

What is the contribution of tumor response in colorectal cancer?

scientific article published in July 2013

[Colon and rectal tumours]

scientific article published on 01 March 2009

[Management of superficial rectal cancers]

scientific article published on 01 July 2008

[What future for circulating tumor DNA? Current data and prospects in colorectal, non-small cell lung and pancreatic cancers].

scientific article

Paulina is supported by:

About Paulina

Help